Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Evolus, Inc.

EOLSNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$5.04
$0.03(0.60%)
U.S. Market opens in 14h 32m

Evolus, Inc. (EOLS) Stock Overview

Explore Evolus, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap327.9M
P/E Ratio-6.30
EPS (TTM)$-0.82
ROE2.68%
Fundamental Analysis

AI Price Forecasts

1 Month$1.93
3 Months$1.28
1 Year Target$0.00

EOLS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Evolus, Inc. (EOLS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 53.33, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -6.30 and a market capitalization of 327.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.60%
5-Day Change
-4.91%
1-Month Change
14.81%
3-Month Change
-30.19%
6-Month Change
-22.70%
Year-to-Date (YTD) Change
-25.00%
1-Year Change
-62.91%
3-Year Change
-40.64%
5-Year Change
-62.44%
All-Time (Max) Change
-56.17%

Contact Information

949 284 4555
520 Newport Center Drive, Newport Beach, CA, 92660

Company Facts

3,720 Employees
IPO DateFeb 8, 2018
CountryUS
Actively Trading

Frequently Asked Questions